Diagnostic Pathology (Oct 2011)

Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas

  • Rubini Corrado,
  • Stramazzotti Daniela,
  • Giantomassi Federica,
  • Costagliola Antonello,
  • Zizzi Antonio,
  • Lucarini Guendalina,
  • Goteri Gaia,
  • Leoni Pietro

DOI
https://doi.org/10.1186/1746-1596-6-97
Journal volume & issue
Vol. 6, no. 1
p. 97

Abstract

Read online

Abstract Background Recently, human germinal center-associated lymphoma (HGAL) gene protein has been proposed as an adjunctive follicular marker to CD10 and BCL6. Methods Our aim was to evaluate immunoreactivity for HGAL in 82 cases of follicular lymphomas (FLs) - 67 nodal, 5 cutaneous and 10 transformed - which were all analysed histologically, by immunohistochemistry and PCR. Results Immunostaining for HGAL was more frequently positive (97.6%) than that for BCL6 (92.7%) and CD10 (90.2%) in FLs; the cases negative for bcl6 and/or for CD10 were all positive for HGAL, whereas the two cases negative for HGAL were positive with BCL6; no difference in HGAL immunostaining was found among different malignant subtypes or grades. Conclusions Therefore, HGAL can be used in the immunostaining of FLs as the most sensitive germinal center (GC)-marker; when applied alone, it would half the immunostaining costs, reserving the use of the other two markers only to HGAL-negative cases.